Home › NDC Lookup › RxCUI directory › RxCUI 1994389

24 HR pregabalin 165 MG Extended Release Oral Tablet [Lyrica] — RxCUI 1994389

RxNorm drug concept · Semantic branded drug
RxCUI 1994389 Semantic branded drug · SBD ● Current RxNorm concept 3 FDA products 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1994389
Official name24 HR pregabalin 165 MG Extended Release Oral Tablet [Lyrica]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known as24 HR Lyrica 165 MG Extended Release Oral Tablet; Lyrica CR 165 MG 24HR Extended Release Oral Tablet
FDA products mapped3
Package NDCs mapped3
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Pregabalin: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Pregabalin is used for a few different conditions depending on which product you're taking. Most commonly it's prescribed for nerve pain — either from diabetes (diabetic peripheral...
  • Yes, dizziness and drowsiness are the most common side effects — and they're the main reason some people end up stopping the medication. They tend to show up shortly after you star...
  • Will pregabalin make me feel dizzy or drowsy?
  • Please don't stop abruptly. Stopping pregabalin suddenly can cause withdrawal symptoms like insomnia, nausea, headache, and anxiety. If you have a seizure disorder, stopping sudden...
📖 Read our full Pregabalin guide →

🕸️ Concept Web — How 24 HR pregabalin 165 MG Extended Release Oral Ta... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 24 HR pregabalin 165 MG Extended Release Oral Tablet [Lyrica] RxCUI 1994389

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Pregabalin 187832
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Lyrica 593441
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Pregabalin Extended Release Oral Tablet 1988973
    • Pregabalin Oral Product 1156764
    • Pregabalin Pill 1156765
    • Pregabalin Extended Release Oral Tablet [Lyrica] 1994388
    • Lyrica Oral Product 1182082
    • Lyrica Pill 1182083
    • Extended Release Oral Tablet 316945
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Brand-Name Concepts

  • Pregabalin 165 MG [Lyrica] SBDC · 1994387
  • Pregabalin Extended Release Oral Tablet [Lyrica] SBDF · 1994388
  • Lyrica Oral Product SBDG · 1182082
  • Lyrica Pill SBDG · 1182083
  • Lyrica BN · 593441

📦 FDA Products & Package NDCs

3 products · 3 package NDCs
3 package NDCs map to RxCUI 1994389 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
58151-0245-93 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (58151-... Lyrica CR Viatris Specialty LLC 2024-11-26
58151-0246-93 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (58151-... Lyrica CR Viatris Specialty LLC 2024-11-26
58151-0247-93 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (58151-... Lyrica CR Viatris Specialty LLC 2024-07-11
Observed labelers: Viatris Specialty LLC (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.